Panacea Biotec jumps 17% on Rs 992 crore fund infusion by Bain-Piramal fund

The deal will help Panacea, which has been under corporate debt restructuring (CDR) since 2014, retire debt of close to Rs 731 crore as on March 31, 2018, and pump in capital to grow business.

from Latest News http://bit.ly/2Z1k4pE
https://ift.tt/eA8V8J http://bit.ly/2SdCH5P

• Tweet
• Share
• Share
• Share
• Share